314 related articles for article (PubMed ID: 19794001)
1. Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.
Bresson D; von Herrath M
Diabetes Care; 2009 Oct; 32(10):1753-68. PubMed ID: 19794001
[No Abstract] [Full Text] [Related]
2. Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future.
Rewers M; Gottlieb P
Diabetes Care; 2009 Oct; 32(10):1769-82. PubMed ID: 19794002
[No Abstract] [Full Text] [Related]
3. Antigen-based therapy for the treatment of type 1 diabetes.
Tian J; Kaufman DL
Diabetes; 2009 Sep; 58(9):1939-46. PubMed ID: 19720821
[No Abstract] [Full Text] [Related]
4. Immune modulation for prevention of type 1 diabetes mellitus.
Raz I; Eldor R; Naparstek Y
Trends Biotechnol; 2005 Mar; 23(3):128-34. PubMed ID: 15734555
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.
Palmer JP
J Clin Invest; 2001 Jul; 108(1):31-3. PubMed ID: 11435453
[No Abstract] [Full Text] [Related]
6. Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes.
Muir A; Schatz D; Maclaren N
Diabetes Metab Rev; 1993 Dec; 9(4):279-87. PubMed ID: 7924825
[No Abstract] [Full Text] [Related]
7. When will immunomodulation for the prevention of type 1 diabetes be a reality?
Leech NJ
Diabet Med; 2003 Jan; 20 Suppl 1():10-3. PubMed ID: 12647834
[No Abstract] [Full Text] [Related]
8. Immunotherapy of type 1 diabetes mellitus.
Chatenoud L
Curr Dir Autoimmun; 2001; 4():333-50. PubMed ID: 11569410
[No Abstract] [Full Text] [Related]
9. Dendritic cell immunotherapy for autoimmune diabetes.
Feili-Hariri M; Flores RR; Vasquez AC; Morel PA
Immunol Res; 2006; 36(1-3):167-73. PubMed ID: 17337777
[TBL] [Abstract][Full Text] [Related]
10. Animal models of type I (insulin-dependent) diabetes mellitus.
Cheţa D
J Pediatr Endocrinol Metab; 1998; 11(1):11-9. PubMed ID: 9642624
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes.
Aly T; Devendra D; Eisenbarth GS
Am J Ther; 2005; 12(6):481-90. PubMed ID: 16280641
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for the prevention and treatment of type 1 diabetes.
Goudy KS; Tisch R
Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
[TBL] [Abstract][Full Text] [Related]
13. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.
Lernmark Å; Larsson HE
J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820
[No Abstract] [Full Text] [Related]
14. IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.
Diaz-de-Durana Y; Lau J; Knee D; Filippi C; Londei M; McNamara P; Nasoff M; DiDonato M; Glynne R; Herman AE
PLoS One; 2013; 8(10):e78483. PubMed ID: 24205242
[TBL] [Abstract][Full Text] [Related]
15. Thinking bedside at the bench: the NOD mouse model of T1DM.
Reed JC; Herold KC
Nat Rev Endocrinol; 2015 May; 11(5):308-14. PubMed ID: 25623120
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy in type I diabetes. Approaches to prevention and treatment.
Colman PG; Eisenbarth GS
Postgrad Med; 1987 May; 81(6):146-55. PubMed ID: 3554198
[TBL] [Abstract][Full Text] [Related]
17. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease.
Bowman MA; Leiter EH; Atkinson MA
Immunol Today; 1994 Mar; 15(3):115-20. PubMed ID: 8172643
[TBL] [Abstract][Full Text] [Related]
18. Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.
Staeva TP; Chatenoud L; Insel R; Atkinson MA
Diabetes; 2013 Jan; 62(1):9-17. PubMed ID: 23258904
[No Abstract] [Full Text] [Related]
19. Current and past prevention and intervention trials in type 1 diabetes.
Staeva T
Novartis Found Symp; 2008; 292():99-109; discussion 109-12, 122-9, 202-3. PubMed ID: 19203095
[TBL] [Abstract][Full Text] [Related]
20. Long-term prevention of diabetes and marked suppression of insulin autoantibodies and insulitis in mice lacking native insulin B9-23 sequence.
Nakayama M; Babaya N; Miao D; Gianani R; Liu E; Elliott JF; Eisenbarth GS
Ann N Y Acad Sci; 2006 Oct; 1079():122-9. PubMed ID: 17130542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
